Exiqon Diagnostics is a market leader in the field of in vitro treatment selection testing for cancer, and performs innovative genomic research aimed at rapidly identifying new cancer diagnostics to improve the outcome for cancer patients.

Cookies on Exiqon's website.
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Exiqon's website.